首页> 外文期刊>Immunology: An Official Journal of the British Society for Immunology >Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.
【24h】

Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.

机译:树突状细胞成熟后,CD205在人树突状细胞中的表达和内吞功能发生改变,并检测到CD205-DCL-1融合蛋白。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

CD205 (DEC-205) is a member of the macrophage mannose receptor family of C-type lectins. These molecules are known to mediate a wide variety of biological functions including the capture and internalization of ligands for subsequent processing and presentation by dendritic cells. Although its ligands await identification, the endocytic properties of CD205 make it an ideal target for those wishing to design vaccines and targeted immunotherapies. We present a detailed analysis of CD205 expression, distribution and endocytosis in human monocyte-derived dendritic cells undergoing lipopolysaccharide-induced maturation. Unlike other members of the macrophage mannose receptor family, CD205 was up-regulated upon dendritic cell maturation. This increase was a result of de novo synthesis as well as a redistribution of molecules from endocytic compartments to the cell surface. Furthermore, the endocytic capacity of CD205 was abrogated and small amounts of the recently identified CD205-DCL-1 fusion protein were detected in mature DC. Our results suggest that CD205 has two distinct functions - one as an endocytic receptor on immature dendritic cells and a second as a non-endocytic molecule on mature dendritic cells - and further highlight its potential as an immuno-modulatory target for vaccine and immunotherapy development.
机译:CD205(DEC-205)是C型凝集素的巨噬细胞甘露糖受体家族的成员。已知这些分子可介导多种生物学功能,包括捕获和内化配体,以供树突状细胞随后加工和呈递。尽管其配体有待鉴定,但CD205的内吞特性使其成为希望设计疫苗和靶向免疫疗法的人们的理想靶标。我们提出了CD205表达,分布和内吞作用的人类单核细胞衍生的树突状细胞经历脂多糖诱导的成熟的详细分析。与巨噬细胞甘露糖受体家族的其他成员不同,CD205在树突状细胞成熟时被上调。这种增加是从头合成以及分子从内吞区室到细胞表面的重新分布的结果。此外,消除了CD205的内吞能力,并且在成熟DC中检测到少量最近鉴定的CD205-DCL-1融合蛋白。我们的研究结果表明CD205具有两个不同的功能-一个作为未成熟树突状细胞上的内吞受体,另一个作为成熟树突状细胞上的非内吞分子-并进一步突显了其作为疫苗和免疫疗法开发的免疫调节靶标的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号